Page last updated: 2024-10-29

iothalamic acid and Hodgkin Disease

iothalamic acid has been researched along with Hodgkin Disease in 2 studies

Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graebner, HF1
Bayindir, S1
Canigiani, G1
Czech, W1

Trials

1 trial available for iothalamic acid and Hodgkin Disease

ArticleYear
[Tolerance of modern contrast media in urologic roentgen diagnosis].
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:4

    Topics: Adult; Aged; Clinical Trials as Topic; Contrast Media; Drug Hypersensitivity; Dysgerminoma; Female;

1970

Other Studies

1 other study available for iothalamic acid and Hodgkin Disease

ArticleYear
[Mediastinal phlebography using the contrast medium Conray 80].
    Rontgenpraxis; Zeitschrift fur radiologische Technik, 1971, Volume: 24, Issue:10

    Topics: Aged; Bronchial Neoplasms; Female; Hodgkin Disease; Humans; Iothalamic Acid; Male; Mediastinal Neopl

1971